| Literature DB >> 34668262 |
Rodney J Hicks1, Clarisse Dromain2, Wouter W de Herder3, Frederico P Costa4, Christophe M Deroose5, Andrea Frilling6, Anna Koumarianou7, Eric P Krenning8, Eric Raymond9, Lisa Bodei10, Halfdan Sorbye11, Staffan Welin12, Bertram Wiedenmann13, Damian Wild14, James R Howe15, James Yao16, Dermot O'Toole17, Anders Sundin18, Vikas Prasad19.
Abstract
The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.Entities:
Keywords: PET; neuroendocrine neoplasia; synoptic reporting
Mesh:
Year: 2021 PMID: 34668262 DOI: 10.1111/jne.13040
Source DB: PubMed Journal: J Neuroendocrinol ISSN: 0953-8194 Impact factor: 3.627